Aurinia Pharmaceuticals to Present at SVB Leerink 10th Annual Global Healthcare Conference

Aurinia Pharmaceuticals Inc. today announced that members of the leadership team will participate in a fireside discussion at SVB Leerink’s 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 1 p.m. 00 ET. In order to participate in the audio webcast, interested parties can access the live webcast under “NewsEvents” through the “Investors” section of Aurinia’s website…

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the management team will participate in a fireside chat at (virtual) SVB Leerink 10 e Annual Global Healthcare Conference Thursday, February 25, 2021 at 1 p.m. ET.

In order to participate in the audio webcast, interested parties can access the live webcast under “News / Events” through the “Investors” section of Aurinia’s website at www.auriniapharma.com . A replay of the webcast will be available on Aurinia’s website.

ABOUT AURINIA

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on providing therapies to treat targeted patient populations who are affected by serious illnesses with a high unmet medical need. The Company introduced LUPKYNIS ™ (voclosporin), the first oral therapy approved by the FDA dedicated to the treatment of adult patients with active lupus nephritis (LN). The Company’s head office is located in Victoria, British Columbia, its US shopping center is in Rockville, Maryland, and the Company focuses its development efforts on a global scale.

Investor contact:
Glenn Schulman, PharmD, MPH
Senior Vice-President, Corporate Communications and RI
[email protected]


Source link

Comments are closed.